Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-111278

Chief Executive Officer sold 10,349 shares at $48.26 ($499,443)

  • Chief Executive Officer acquired 20,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-14 Exercise or conversion : show line 1 in the form +20,625 256,183 D
2026-03-16 Sale : show line 2 in the form −10,349 $48.26 $499,443 245,834 D
Open-market sales · 10,349 sh · avg $48.26 · $499,443

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −20,625 61,875 D
Loading xslF345X05/ownership.xml…